News

132 items
  • VPH partners in two new EC projects: CHAIN and AIGENT

    CHAIN and AIGENT kick off, strengthening European collaboration in artificial intelligence, digital twins and in silico medicine.

    Discover more
  • ARPA-H Launches SURPASS Program to accelerate Clinical Trials

    The initiative aims to reduce clinical trial timelines to less than four years through artificial intelligence, predictive computational models and adaptive trial designs.

    Discover more
  • Investment in In-Silico Regulatory Science could boost UK growth and patient health

    Office of Health Economics's report highlights the potential health, economic and industry benefits of investing in the UK Centre of Excellence for In-Silico Regulatory Science and Innovation, provided adequate funding is secured.

    Discover more
  • MHRA Strategy 2030 highlights in-silico evidence, digital twins and hybrid trials

    The UK regulator plans new guidance and regulatory frameworks to advance computational evidence, digital twins and synthetic data in medicines development and clinical trials.

    Discover more
  • Final Call for Input on the AI & Virtual Human Twins Joint Statement

    The HPP Thematic Network on "Building Responsible Ecosystem Solutions: AI and Virtual Human Twins in Healthcare" is entering its final phase and invites stakeholders to contribute their feedback to the draft Joint Statement.

    Discover more
  • In Silico Evidence Training for Frontline Regulatory Reviewers

    The UK Centre of Excellence on In Silico Regulatory Science and Innovation (UK CEiRSI) kicked off its two-day training workshop in London on 14–15 October 2026, at the invitation of the International Medical Device Regulators Forum (IMDRF)

    Discover more
  • Advanced VHT Platform Annual Event 2026

    Bringing the European Virtual Human Twin community together in Brussels to share progress, strengthen collaboration and shape the next steps towards the Advanced VHT Platform.

    Discover more
  • NIH Call: Digital Twins for Biomedical, Biological and Behavioral Research

    The U.S. National Institutes of Health (NIH) is highlighting new research opportunities in Digital Twins for Biomedical, Biological, and Behavioral Research, supporting innovative approaches to accelerate scientific discovery and advance healthcare technologies.

    Discover more
  • European Parliament advances MDR/IVDR revision: critical implications for In Silico & Digital Health Technologies

    As the European Union moves forward with revising Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR), the European Parliament’s Committee on Environment, Public Health and Food Safety (SANT) is taking a central role in recalibrating the MedTech regulatory landscape.

    Discover more
  • EMA launches Pre-Submission Interactions pilot to improve MAA readiness

    The European Medicines Agency (EMA) has initiated a voluntary pilot testing a revised model for Pre-Submission Interactions (PSI) ahead of initial Marketing Authorisation Applications (MAAs).

    Discover more
  • From Credibility to Trust

    On 3 September 2026, during the VPH Conference in Milan, VPH hosted a plenary roundtable "From Credibility to Trust".

    Discover more
  • JRC at the 9th International VPH Conference

    The European Commission’s Joint Research Centre (JRC) played an active role in the VPH2026 Conference, held in Milan, bringing its expertise in computational modelling and in silico medicine to discussions on the future of healthcare.

    Discover more